01.01.05
Pharmanex, Provo, UT, has concluded a scientific study meant to further validate the Pharmanex BioPhotonic Scanner. The study, “Clinical Validation of a Novel Raman Spectroscopic Technology to Non-Invasively Assess Carotenoid Status in Humans,” was presented by Dr. Carsten Smidt, vice president of global research and development for Pharmanex, at the 45th annual meeting of the American College of Nutrition (ACN). The study showed that the Pharmanex BioPhotonic Scanner produced measurements with less variability than blood carotenoids measured by conventional high performance liquid chromatography (HPLC) methods. The study also found a correlation between the BioPhotonic Scanner scores and blood carotenoids, the current accepted gold standard in research.